Switch to:
More From Other Websites
Activists want 'imminent retirement' of Ariad CEO Feb 20 2015
Merck Snags Cubist, Fighter of Superbugs, for $9.5B Dec 08 2014
Biotech targets: Cramer's quality candidates Sep 11 2014
UPDATE: Deutsche Bank Initiates Coverage On Merck Aug 27 2014
Achillion Pharmaceuticals Up On Buyout Rumors Aug 18 2014
Ukraine Tension Prominent As Dow Suffers Triple Digit Loss; S&P 500 & NASDAQ Also Lower Aug 05 2014
IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Aug 05 2014
IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 31 2014
IDENIX PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Jul 31 2014
Merck 2Q profit more than doubles Jul 29 2014
Every Which Way But Short Jul 24 2014
US STOCKS-Wall St edges up, lifted by mergers, acquisitions Jun 10 2014
Merck buys Idenix to boost hepatitis C work Jun 09 2014
Why Merck Just Spent $4 Billion On New Drugs For Hepatitis C Jun 09 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Bradlewski
ReplyBradlewski - 1 year ago
Merck is buying it for $24.5/share.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK